ZOE Stock

ZOE is a personalized nutrition company on a mission to improve the health of millions.

Sign up today and learn more about ZOE Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About ZOE Stock

ZOE is a personalized nutrition company that operates the world's largest nutrition-science study, as well as the ZOE Health Study (formerly ZOE COVID Study). It improves the health of millions by utilizing data on a previously unimagined scale and unraveling the complex relationship between food, lifestyle, and health. The ZOE program begins with an at-home test and provides members with personalized advice on how to eat for their bodies and long-term health. Its science is based on the realization that everyone reacts differently to food and that gut bacteria play an important role in health. ZOE research has been published in peer-reviewed journals such as Nature Medicine, Nature Metabolism, The Lancet, Gut, and others.

Funding History

August 2018$8.0M
January 2019$19.0M
May 2021$20.0M
December 2022$7.4M
December 2022$30.0M
March 2023$2.5M


Cofounder & President

George Hadjigeorgiou

Head of Product

Elana Jeeaooo

Advisory Board Member

Julien Cornebise

Engineering Manager

Somesh Selvachandran

Cofounder & CEO

Jonathan Wolf


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: